Price History
Apr 5, 2026 — May 15, 2026Investment Snapshot
- P/B of 11.34 — trading above book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -17.9%
Veradermics, Incorporated Common Stock (MANE) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NYSE , with a market capitalisation of $4.4 billion . Key value metrics: P/B ratio 11.34, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Veradermics, Incorporated Common Stock — Fundamental Analysis Summary
On financial health, MANE shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -17.9% (sector average: -20.6%).
StockPik's composite Value Score for MANE is 25/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MANE shows earnings declining at 164%.